A Multicenter Randomized Clinical Trial Evaluating Interleukin-2 Activated Hematopoietic Stem Cell Transplantation and Post-transplant IL-2 for High Risk Breast Cancer PatientsClaudine Isaacs, Marc E. Lippman, Edmund A. Gehan et al.|Breast Cancer Research and Treatment|2005Cited by 3